SAM
Silvercrest Asset Management’s United Therapeutics UTHR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $378K | Buy |
1,316
+153
| +13% | +$44K | ﹤0.01% | 742 |
|
|
2025
Q1 | $359K | Buy |
1,163
+186
| +19% | +$57.3K | ﹤0.01% | 748 |
|
|
2024
Q4 | $345K | Buy |
977
+56
| +6% | +$19.8K | ﹤0.01% | 742 |
|
|
2024
Q3 | $330K | Sell |
921
-305
| -25% | -$109K | ﹤0.01% | 709 |
|
|
2024
Q2 | $391K | Buy |
1,226
+32
| +3% | +$10.2K | ﹤0.01% | 763 |
|
|
2024
Q1 | $274K | Buy |
1,194
+14
| +1% | +$3.22K | ﹤0.01% | 810 |
|
|
2023
Q4 | $259K | Sell |
1,180
-14
| -1% | -$3.08K | ﹤0.01% | 763 |
|
|
2023
Q3 | $270K | Buy |
1,194
+43
| +4% | +$9.71K | ﹤0.01% | 761 |
|
|
2023
Q2 | $254K | Buy |
+1,151
| New | +$254K | ﹤0.01% | 771 |
|
|
2023
Q1 | – | Sell |
-832
| Closed | -$231K | – | 816 |
|
|
2022
Q4 | $231K | Sell |
832
-381
| -31% | -$106K | ﹤0.01% | 740 |
|
|
2022
Q3 | $254K | Sell |
1,213
-508
| -30% | -$106K | ﹤0.01% | 728 |
|
|
2022
Q2 | $406K | Sell |
1,721
-402
| -19% | -$94.8K | ﹤0.01% | 676 |
|
|
2022
Q1 | $381K | Buy |
2,123
+116
| +6% | +$20.8K | ﹤0.01% | 728 |
|
|
2021
Q4 | $434K | Buy |
+2,007
| New | +$434K | ﹤0.01% | 698 |
|